Penn., N.J. Health Systems Form Clinical Research Consortium | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Penn., N.J. Health Systems Form Clinical Research Consortium

April 17, 2018
by David Raths
| Reprints
Goal is to speed up the clinical trial process

Six health systems in New Jersey and Pennsylvania have announced the founding of a nonprofit clinical research consortium – Partners in Innovation, Education, and Research (PIER Consortium) to streamline clinical trials.

The founding members of PIER Consortium include Atlantic Health System, Drexel University, Einstein Healthcare Network, Geisinger including AtlantiCare, Main Line Health and Thomas Jefferson University. 

Clinical trials have traditionally been offered at academic medical centers and through affiliated hospitals to ensure patients are treated safely and effectively with the best standard of care. Unfortunately for patients, this can mean traveling many miles, sometimes across the country, for novel treatment. The PIER Consortium will bring clinical trial sites to larger numbers of patients, while also bringing new treatments to market faster. 

The goal of having a broad network of physician-researchers is to speed up the clinical trial process and deliver effective therapies to patients sooner. “It can take decades to prove a medication or other treatment is safe and effective for a particular disease, which can be too late for many patients seeking treatment,” said David Whellan, M.D., senior associate provost for clinical research at Jefferson and chief operating officer of PIER, in a prepared statement.

An estimated 80 percent of clinical trials fail to finish on time. Having contracts in place and physicians identified could allow trials to both start and reach participation capacity more quickly. The expertise shared across sites through PIER will allow clinical researchers to enroll patients in trials more quickly and streamline the clinical trial process across institutions. This will create a more effective process for patients, trial sponsors, and researchers. 

“PIER offers turn-key solutions with one contract and a single Institutional Review Board (IRB),” Whellan added. “With physician champions at each site, start-up activities will be coordinated to help each site hit the ground running.”

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

AHRQ Launches App Challenge for PRO Data Standardization

The Agency for Healthcare Research and Quality (AHRQ) has launched a competition to address the need for greater use of standardized patient-reported outcomes (PRO) data in clinical care and research.

Study: Many U.S. Hospitals won’t Reach HIMSS Stage 7 Until 2035

Unless the healthcare IT ecosystem experiences major policy changes or leaps in technological capabilities, many hospitals will not reach Stage 7 of HIMSS Analytics’ Electronic Medical Record Adoption Model until 2035, according to new research.

Amazon, Google, IBM and Other Tech Giants Pledge to Remove Barriers to Interoperability

Six of the world's biggest technology companies, including Microsoft, Google, IBM and Amazon, made a joint pledge at the White House Monday to remove interoperability barriers and to make progress on adoption of health data standards.

Mayo Clinic Elects New President and CEO

Gianrico Farrugia, M.D., current vice president, Mayo Clinic, and CEO of Mayo Clinic in Florida has been elected as the president and CEO of the Mayo Clinic, headquartered in Minnesota.

Fitbit, Blue Cross Blue Shield Launch Mobile Health Partnership

San Francisco-based fitness wearable maker Fitbit continues its push into the health plan market with a new digital health deal to incorporate its fitness tracker into health and wellness programs.

ASCO Picks IBM Watson Exec to Lead CancerLinQ

The American Society of Clinical Oncology (ASCO) has named a former IBM Watson executive as the new CEO of its CancerLinQ big data platform.